Strategic Advisors LLC Amgen Inc Transaction History

Strategic Advisors LLC

$530 Million
Q3 2024

A detailed history of Strategic Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Strategic Advisors LLC holds 6,827 shares of AMGN stock, worth $1.8 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

6,827

Previous 6,842 0.22%

Holding current value

$1.8 Million

Previous $2.14 Million 2.9%

% of portfolio

0.42%

Previous 0.42%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	SELL	$309.38 - $337.38 $4,640 - $5,060	-15 Reduced 0.22%	6,827 $2.2 Million
Q2 2024 Jul 11, 2024	SELL	$262.75 - $319.31 $3,678 - $4,470	-14 Reduced 0.2%	6,842 $2.14 Million
Q1 2024 Apr 19, 2024	SELL	$268.87 - $324.56 $5.05 Million - $6.1 Million	-18,786 Reduced 73.26%	6,856 $1.95 Million
Q4 2023 Jan 19, 2024	BUY	$255.7 - $288.46 $13,040 - $14,711	51 Added 0.2%	25,642 $7.39 Million
Q3 2023 Oct 13, 2023	BUY	$218.65 - $271.46 $21,427 - $26,603	98 Added 0.38%	25,591 $6.88 Million
Q2 2023 Jul 31, 2023	BUY	$214.27 - $253.37 $428 - $506	2 Added 0.01%	25,493 $5.66 Million
Q1 2023 Apr 27, 2023	BUY	$225.79 - $275.2 $225 - $275	1 Added 0.0%	25,491 $6.16 Million
Q4 2022 Jan 23, 2023	SELL	$229.03 - $291.01 $36,873 - $46,852	-161 Reduced 0.63%	25,490 $0
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $57,910 - $65,312	258 Added 1.02%	25,651 $5.78 Million
Q2 2022 Aug 03, 2022	BUY	$230.71 - $256.74 $461 - $513	2 Added 0.01%	25,393 $6.18 Million
Q1 2022 May 10, 2022	SELL	$219.27 - $242.57 $33,109 - $36,628	-151 Reduced 0.59%	25,391 $6.14 Million
Q4 2021 Jan 21, 2022	BUY	$198.88 - $227.6 $3.75 Million - $4.29 Million	18,844 Added 281.34%	25,542 $5.75 Million
Q3 2021 Oct 21, 2021	BUY	$212.27 - $248.7 $1.42 Million - $1.67 Million	6,698 New	6,698 $1.42 Million
Q3 2019 Oct 17, 2019	SELL	$174.11 - $208.62 $224,253 - $268,702	-1,288 Closed	0 $0
Q2 2019 Jul 22, 2019	SELL	$166.7 - $195.41 $61,345 - $71,910	-368 Reduced 22.22%	1,288 $237,000
Q1 2019 Apr 15, 2019	BUY	$180.87 - $203.88 $723 - $815	4 Added 0.24%	1,656 $315,000
Q4 2018 Jan 24, 2019	SELL	$178.4 - $208.25 $37,107 - $43,316	-208 Reduced 11.18%	1,652 $322,000
Q3 2018 Oct 18, 2018	SELL	$185.29 - $208.89 $123,403 - $139,120	-666 Reduced 26.37%	1,860 $386,000
Q2 2018 Jul 30, 2018	SELL	$166.05 - $186.51 $88,338 - $99,223	-532 Reduced 17.4%	2,526 $466,000
Q1 2018 Apr 19, 2018	SELL	$169.43 - $198.0 $8,979 - $10,494	-53 Reduced 1.7%	3,058 $521,000
Q4 2017 Jan 16, 2018	SELL	$168.79 - $188.59 $123,047 - $137,482	-729 Reduced 18.98%	3,111 $541,000
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $79,295 - $90,534	474 Added 14.08%	3,840 $716,000
Q2 2017 Aug 10, 2017	BUY	N/A	3,366	3,366 $580,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Advisors LLC with notifications on news.

Account

Strategic Advisors LLC Amgen Inc Transaction History